Yew Bio-Pharm Group, Inc. (CIK: 0001548240) EDGAR, Information, Filings... CompaniesBIO.Com

Yew Bio-Pharm Group, Inc.

Mailing address
9460 TELSTAR AVENUE, SUITE 6, EL MONTE, Nevada, 91731
Phone
626-401-9588
State location
California
State of incorporation
Nevada
Fiscal year end
December 31
SIC
0100 - (CF Office: Office of Life Sciences) AGRICULTURAL PRODUCTION-CROPS
Filings
N/A

Yew Bio-Pharm Group, Inc. (CIK: 0001548240) is an American company incorporated in the state of California. Head office is located at 9460 TELSTAR AVENUE, SUITE 6, EL MONTE, California, 91731. Work in the industry 0100 - (CF Office: Office of Life Sciences) AGRICULTURAL PRODUCTION-CROPS. Yew Bio-Pharm Group, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Shi Yongchun	0001822285	Dec-02-2019	director
Liu Xiefeng	0001822288	Dec-02-2019	director
Tian Guoshuang	0001822296	Dec-02-2019	director
Wu Xuehai	0001822275	Oct-06-2015	director
Han Xingming	0001548241	Dec-13-2012	director
WASSERMAN ADAM C	0001171265	Jul-09-2012	officer: Chief Financial Officer
Qi Guifang	0001548242	Jul-09-2012	director, officer: Treasurer
Wang Zhiguo	0001548243	Jul-09-2012	director, officer: President and Secretary

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Yew Bio-Pharm Group, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
REVOKED	Document	Acc-no: 9999999997-23-004633 (34 Act) Size: KB	Nov-09-2023	000-54701 231390313
8-K	Document	Current report filing Acc-no: 0001493152-22-007955 (34 Act) Size: KB	Mar-29-2022	000-54701 22777511
DEFA14C	Document	Definitive additional information statement materials including Rule 14(a)(12) material Acc-no: 0001493152-21-030003 (34 Act) Size: KB	Nov-29-2021	000-54701 211456133
DEF 14C	Document	Definitive information statements Acc-no: 0001493152-21-030000 (34 Act) Size: KB	Nov-29-2021	000-54701 211456112
PRE 14C	Document	Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001493152-21-028625 (34 Act) Size: KB	Nov-15-2021	000-54701 211411006
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-028337 (34 Act) Size: KB	Nov-15-2021	000-54701 211406432
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-020137 (34 Act) Size: KB	Aug-16-2021	000-54701 211177791
8-K	Document	Current report filing Acc-no: 0001493152-21-017857 (34 Act) Size: KB	Jul-27-2021	000-54701 211117956
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-21-011687 (34 Act) Size: KB	May-17-2021	000-54701 21927760
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-21-007242 (34 Act) Size: KB	Mar-30-2021	000-54701 21788398
8-K	Document	Current report filing Acc-no: 0001493152-21-000204 (34 Act) Size: KB	Jan-05-2021	000-54701 21505336
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-20-021299 (34 Act) Size: KB	Nov-13-2020	000-54701 201311339
DEFA14C	Document	Definitive additional information statement materials including Rule 14(a)(12) material Acc-no: 0001213900-20-030992 (34 Act) Size: KB	Oct-13-2020	000-54701 201234849
DEF 14C	Document	Definitive information statements Acc-no: 0001213900-20-030989 (34 Act) Size: KB	Oct-13-2020	000-54701 201234843
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001822275-20-000001 ( Act) Size: 0 KB	Sep-29-2020
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001822285-20-000001 ( Act) Size: 0 KB	Sep-29-2020
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001822288-20-000001 ( Act) Size: 0 KB	Sep-29-2020
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001822296-20-000001 ( Act) Size: 0 KB	Sep-29-2020
PRE 14C	Document	Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001213900-20-028668 (34 Act) Size: KB	Sep-28-2020	000-54701 201204457
8-K	Document	Current report filing Acc-no: 0001213900-20-026609 (34 Act) Size: KB	Sep-15-2020	000-54701 201175369

Recent 20 filings. View all Yew Bio-Pharm Group, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Yew Bio-Pharm Group, Inc. overview
Yew Bio-Pharm Group, Inc. job
Yew Bio-Pharm Group, Inc. stock
Yew Bio-Pharm Group, Inc. ownership
Yew Bio-Pharm Group, Inc. CEO
Yew Bio-Pharm Group, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.